JP2024522095A5 - - Google Patents

Info

Publication number
JP2024522095A5
JP2024522095A5 JP2023572771A JP2023572771A JP2024522095A5 JP 2024522095 A5 JP2024522095 A5 JP 2024522095A5 JP 2023572771 A JP2023572771 A JP 2023572771A JP 2023572771 A JP2023572771 A JP 2023572771A JP 2024522095 A5 JP2024522095 A5 JP 2024522095A5
Authority
JP
Japan
Prior art keywords
seq
sequence
identity
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522095A (ja
Filing date
Publication date
Priority claimed from GBGB2107517.1A external-priority patent/GB202107517D0/en
Priority claimed from GBGB2116709.3A external-priority patent/GB202116709D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/051285 external-priority patent/WO2022248839A1/en
Publication of JP2024522095A publication Critical patent/JP2024522095A/ja
Publication of JP2024522095A5 publication Critical patent/JP2024522095A5/ja
Pending legal-status Critical Current

Links

JP2023572771A 2021-05-26 2022-05-20 抗体 Pending JP2024522095A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2107517.1A GB202107517D0 (en) 2021-05-26 2021-05-26 Antibodies
GB2107517.1 2021-05-26
GBGB2116709.3A GB202116709D0 (en) 2021-11-19 2021-11-19 Antibodies
GB2116709.3 2021-11-19
PCT/GB2022/051285 WO2022248839A1 (en) 2021-05-26 2022-05-20 Antibodies

Publications (2)

Publication Number Publication Date
JP2024522095A JP2024522095A (ja) 2024-06-11
JP2024522095A5 true JP2024522095A5 (enExample) 2025-05-27

Family

ID=81927992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572771A Pending JP2024522095A (ja) 2021-05-26 2022-05-20 抗体

Country Status (9)

Country Link
US (1) US20240383986A1 (enExample)
EP (1) EP4347045A1 (enExample)
JP (1) JP2024522095A (enExample)
KR (1) KR20240013781A (enExample)
AU (1) AU2022282828A1 (enExample)
CA (1) CA3220308A1 (enExample)
IL (1) IL308782A (enExample)
MX (1) MX2023013979A (enExample)
WO (1) WO2022248839A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025043244A1 (en) * 2023-08-24 2025-02-27 Arizona Board Of Regents On Behalf Of Arizona State University Tandem antigen capture assays for measuring qsox1 isoforms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4712724B2 (ja) * 2003-12-23 2011-06-29 クルセル ホランド ベー ヴェー CD1aに対するヒト結合分子
WO2015042110A1 (en) * 2013-09-20 2015-03-26 Children's Medical Center Corporation Treatment of inflammatory skin disease
EP3696191A1 (en) * 2019-02-14 2020-08-19 Fundación Instituto de Investigación contra la Leucemia Josep Carreras (IJC) Car t-cells for the treatment of cd1a-positive cancer

Similar Documents

Publication Publication Date Title
JP6837105B2 (ja) Il−4r阻害剤の投与による好酸球性食道炎を治療する方法
JP6637113B2 (ja) Il−4rアンタゴニストを投与することによるアトピー性皮膚炎を処置するための方法
JP7315545B2 (ja) Il-4r拮抗薬の投与により喘息を処置または予防するための方法
JP5944382B2 (ja) 汗腺膿瘍(hs)の治療のための使用および組成物
JP2023527775A (ja) Il-4r阻害剤の投与により好酸球性食道炎を処置する方法
KR20090088932A (ko) 전신 홍반성 낭창의 치료 방법
KR20190082815A (ko) 중화 항-tl1a 단일 클론 항체
RS65652B1 (sr) Postupci lečenja bolesti u kojima je dejstvo il-13 štetno pomoću antitela protiv il-13
EP2999484A1 (en) Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma
JP2025164767A (ja) Il-33アンタゴニストを投与することによりcopdを治療するための方法
JP2023549872A5 (enExample)
JP2025188113A (ja) 免疫療法に対する腫瘍応答およびその毒性を予測するためのバイオマーカー
WO2025021131A1 (en) Methods of treating alopecia areata and atopic dermatitis
CN121001741A (zh) 用于通过施用il-4r拮抗剂治疗嗜酸粒细胞性胃肠炎的方法
JP6901545B2 (ja) Il−4rアンタゴニストを投与することによるアトピー性皮膚炎を処置するための方法
WO2019074912A1 (en) ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS
WO2023168404A1 (en) Methods of treating a tumor
WO2023021006A1 (en) Il-1 targeting agents for treatment of pitiyriasis rubra pilaris
EP4370550A1 (en) Use of il-36 inhibitors for the treatment of netherton syndrome
EA045955B1 (ru) Способы лечения заболеваний, при которых активность il-13 оказывает негативное влияние, с применением антител против il-13